Overview

Single and Multiple Dose Study in Japanese

Status:
Completed

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

This study will explore the safety, tolerability, and serum uric acid lowering effect of lesinurad in healthy Japanese males to allow comparison with the Western population.

Phase:

Phase 1

Details

Lead Sponsor:

Ardea Biosciences, Inc.

Treatments:

Lesinurad